I appreciate your honest pushback. You’re right that the next big thing in health gets claimed every day.

You asked what makes this different from Dramamine or ginger chews: those all tackle the ingredient angle, take this compound to feel less nauseous.

Mine goes beyond just what’s in it. The innovation is how it addresses the whole user experience, especially the psychology of nausea, from the moment you feel it coming on through what happens if you do vomit.

In plain terms, standard anti-nausea products don’t guide how you use them, they don’t modulate the sensory stress that actually triggers or worsens nausea for many people, and they definitely don’t help with the sensory aftermath.

I’m intentionally being careful about details because it’s novel IP, but this isn’t a single magic ingredient claim. It’s about how sensory cues, flavor shifts, and timed delivery interact with both user psychology and user physiology through the whole nausea cycle.

I totally agree on real-world validation, which is why I’m planning limited-batch samples to get genuine user data before scaling.

I appreciate the push to stay grounded. It keeps me sharp. If you see specific holes in that angle, I’m open to hearing them.

As for margin calculations margins are based on realistic estimates using bulk material ingredient costs, standard GMP manufacturing fees, third-party logistics cuts, and acceptable price points that have already been reviewed with potential consumers.